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Acinetobacter baumannii is one of the most important nosocomial pathogens able
to rapidly develop extensive drug resistance. Here, we study the role of accessory
genome in the success of the globally disseminated clone 1 (GC1) with functional
and genomic approaches. Comparative genomics was performed with available GC1
genomes (n = 106) against other A. baumannii high-risk and sporadic clones. Genetic
traits related to accessory genome were found common and conserved along time
as two novel regions of genome plasticity, and a CRISPR-Cas system acquired
before clonal diversification located at the same loci as “sedentary” modules. Although
identified within hotspot for recombination, other block of accessory genome was
also “sedentary” in lineage 1 of GC1 with signs of microevolution as the AbaR0-type
genomic island (GI) identified in A144 and in A155 strains which were maintained
one month in independent experiments without antimicrobial pressure. The prophage
YMC/09/02/B1251_ABA_BP was found to be “mobile” since, although it was shared
by all GC1 genomes, it showed high intrinsic microevolution as well as mobility
to different insertion sites. Interestingly, a wide variety of Insertion Sequences (IS),
probably acquired by the flow of plasmids related to Rep_3 superfamily was found.
These IS showed dissimilar genomic location amongst GC1 genomes presumably
associated with promptly niche adaptation. On the other hand, a type VI secretion
system and three efflux pumps were subjected to deep processes of genomic loss
in A. baumannii but not in GC1. As a whole, these findings suggest that preservation
of some genetic modules of accessory genome harbored by strains from different
continents in combination with great plasticity of IS and varied flow of plasmids, may
be central features of the genomic structure of GC1. Competition of A144 and A155
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versus A118 (ST 404/ND) without antimicrobial pressure suggested a higher ability of
GC1 to grow over a clone with sporadic behavior which explains, from an ecological
perspective, the global achievement of this successful pandemic clone in the hospital
habitat. Together, these data suggest an essential role of still unknown properties of
“mobile” and “sedentary” accessory genome that is preserved over time under different
antibiotic or stress conditions.
Keywords: A. baumannii, international clone 1 (GC1), accessory genome, genomic plasticity, high-risk clone
INTRODUCTION
The broad diversification of species among the genus
Acinetobacter occurred mostly due to Lateral Genetic Transfer
(LGT) events, and to some allelic recombination at specific
hotspots (Touchon et al., 2014; Holt et al., 2016). The size of
the pangenome of A. baumannii has larger values than the rest
of species within the genus, evidencing also a high biochemical
diversity (Touchon et al., 2014; Chan et al., 2015). A. baumannii
is well known as an opportunistic pathogen mainly implicated in
ventilator-associated pneumonia, catheter-related bloodstream,
urinary tract, and wound infections (Falagas et al., 2006; Peleg
et al., 2008; Roca et al., 2012; Park et al., 2013; Inchai et al., 2015).
This species has a highly plastic genome evidenced by the amount
of insertions, deletions, inversions and SNPs reported (Peleg
et al., 2008; Imperi et al., 2011; Antunes et al., 2014), which may
contribute to its adaptation to several niches and the evolution
to extensive (XDR) and pandrug resistance (PDR) phenotypes
(Adams et al., 2008; Vallenet et al., 2008; Arduino et al., 2012; Ou
et al., 2015; Holt et al., 2019), harboring a pangenome of over
9000 gene families (Antunes et al., 2011; Touchon et al., 2014).
Comparative typing of European outbreak strains of
A. baumannii demonstrated the occurrence of three successful
clones identified as “International Clones I–III” (IC1-3), or
also known as Global Clones (GC) (Diancourt et al., 2010).
Homologous recombination near the origin of replication was
the mechanism associated with the diversification of these GC
(Snitkin et al., 2013).
Global Clone 1 has been showed to have a broad international
distribution in more than 30 countries from all continents (Karah
et al., 2012). Regarding to the evolutionary trajectory of GC1,
genomic studies showed that the most recent common ancestor
emerged in the 1960s and then diverged into two phylogenetically
distinct lineages (Holt et al., 2016; Hamidian et al., 2019). In
the 1970s, the main lineage acquired an AbaR0-type GI where
the resistance mechanisms to the older antibiotics usually are
found (Holt et al., 2016). This epidemic clone has diversified into
multiple successful extensively antibiotic-resistant subclones that
differ in their surface structures (Holt et al., 2016). Concerning
the genomic topology of GC1, four hotspots of recombination
non-related to the accessory genome were identified within GC1
(Holt et al., 2016). From those, two hotspots of recombination
are associated with biosynthesis of exopolysaccharides via the K
locus and OC locus, the third is the gene encoding the outer
membrane protein CarO, and the fourth introduces resistance
to third-generation cephalosporins via the insertion sequence-
enhanced expression of the intrinsic AmpC β-lactamase (Holt
et al., 2016). Also, two CRISPR-Cas systems have been identified
in some strains of A. baumannii (Di Nocera et al., 2011;
Hauck et al., 2012). The AYE strain, whose genome is taken in
many studies as the basis for GC1 studies (Touchon et al.,
2014; Karah et al., 2015), and other A. baumannii clones were
identified to harbor the subtype I-Fb, indicating potential inter-
strain horizontal transfer of this CRISPR-Cas system (Di Nocera
et al., 2011; Karah et al., 2015). Based on distinct assortment
of spacers harbored by each strain, a CRISPR-based sequence
type (Schouls et al., 2003) identified a subclone of A. baumannii
GC1 that it is likely it has been originated in Iraq and spread
later to the United States and Europe (Karah et al., 2015). Holt
et al. (2016) reported the existence of two lineages within GC1.
Lineage 1 genomes carried an AbaR0-type island with a Tn6019–
like element inserted within the comM gene (Hamidian et al.,
2014; Holt et al., 2016). In turn, a deletion in intI1 defines
AbaR3-type GI (Holt et al., 2016). Successive microevolution
of AbaR0 and AbaR3-types includes acquisition and loss of
Antimicrobial Resistance Genes (ARG), which gave rise to the
different island scaffolds (Post and Hall, 2009; Post et al., 2010,
2012; Krizova et al., 2011; Nigro et al., 2011; Holt et al., 2016).
Lineage 2 genomes either lack a transposon in comM or had
acquired the transposon Tn6022 or its variants which may
lead to the formation of AbaR4 GI (Hamidian and Hall, 2011;
Holt et al., 2016).
Concerning our local epidemiology, recent studies of
Carbapenem Resistant A. baumannii (CRAB) isolates, revealed
that GC1 is the most widespread and common clone of CRAB in
Argentina (Rodríguez et al., 2018).
Previously, we reported the genome of A144 (CC1/CC231)
and A155 (CC1/CC231) A. baumannii strains from Argentina
which belonged to GC1 (Vilacoba et al., 2014; Arivett et al., 2015).
These strains were isolated in the 1990s when carbapenems were
recently introduced in Argentina (Vilacoba et al., 2014). Since at
that time clonal complex CC113 was predominant (Stietz et al.,
2013), A155 (CC1/CC231) was considered among the first GC1
isolates in Argentina (Ramírez et al., 2013).
The aim of this work was to examine the role of the accessory
genome of the high-risk clone GC1 across time and continents
from genomic and functional approaches. Although previous
comparative genomic studies evidenced genetic variability across
all A. baumannii strains (Adams et al., 2008; Vallenet et al., 2008;
Di Nocera et al., 2011; Sahl et al., 2013; Touchon et al., 2014;
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Holt et al., 2019; Meumann et al., 2019), no data, excluding
evolution to antimicrobial resistance (Karah et al., 2017;
Hamidian and Hall, 2018b; Holt et al., 2019), is focused on
the features of the accessory genome of prevalent clones.
Interestingly, two patterns of preservation of the accessory
genome within GC1 strains regardless their site or time of
isolation were found: (i) “sedentary” modules such as two novel
regions of genome plasticity, the AbaR GI in lineage 1, and
even a CRISPR-Cas type-If system located in the same loci; and
(ii) a “mobile” module as the case of the putative prophage
YMC/09/02/B1251_ABA_BP shared by all 106 GC1 genomes
which showed high genomic plasticity evidenced by intrinsic
microevolution as well as mobility to different insertion sites
amongst GC1’s chromosomes. Because AbaR GI is widespread
among A. baumannii clinical samples, particularly in GC1, this
GI was used as a biological model for comparative genomics and
experimental studies of maintenance. We found that AbaR0-type
GI from A144 (CC1/CC231) as well as in A155 (CC1/CC231)
was maintained at least over one month in three independent
experiments without antimicrobial pressure, while in silico
analysis revealed AbaR0-type GI were all different including
AbaR0-type GI from A144 (CC1/CC231) which showed signs of
microevolution events compared to A155 (CC1/CC231). On the
other hand, a Type VI Secretion System (T6SS) and three efflux
pumps showed to be subjected to deep processes of genomic
loss in A. baumannii but not in GC1. As a whole, these studies
highlighted that the conservation of genetic elements of the
accessory genome may play a still unknown role in the success
of this high-risk clone.
MATERIALS AND METHODS
Bacterial Strains Used for Experimental
Assays
The multidrug resistant GC1 A. baumannii A144 and A155
strains (CC1/CC231), and A118 (ST 404/ND) which belongs
to an sporadic clone were isolated from the same hospital H1
from Argentina in 1997 (Vilacoba et al., 2014), 1994 (Arivett
et al., 2015), and 1995 (Traglia et al., 2014), respectively.
These strains that were available in our laboratory were used
to perform experimental investigation concerning maintenance
of accessory genome along time as well as clone competition
assays (see below).
Previous DNA Sequencing of H1 Strains
Strains from H1 Hospital from Argentina, A. baumannii A144
and A155 (CC1/CC231), and the sporadic clone A118 (ST
404/ND) that were the basis of this study, were previously
sequenced (Traglia et al., 2014; Vilacoba et al., 2014; Arivett
et al., 2015). Briefly, Whole-Genome Shotgun (WGS) sequencing
was performed using Illumina MiSeq-I, using Nextera XT
libraries for sample preparation. Reads were assembled with Ray
assembler1. The draft genome sequence of A144 (CC1/CC231)
consist of 92 contigs (length > 500 bp), a total sequence
1http://denovoassembler.sourceforge.net
of 4,312,914 bp with an N50 contig size of 89,819. The
GC% average was 39.2. Using RAST (Aziz et al., 2008) we
identified 4,151 possible ORFs, 74 copies of 16S-23S-5S rRNA
operons and 69 tRNA genes (Vilacoba et al., 2014). The WGS
project has been deposited at DDBJ/EMBL/GenBank under the
Accession Number (AN) JQSF00000000. The de novo assembly
of A155 (CC1/CC231) resulted in a 3,933,455 bp genome
encoding 55 tRNAs and 3,760 genes with 3,704 proposed
CDSs (Arivett et al., 2015). The first version of the de novo
whole-genome assembly of A155 (CC1/CC231) was deposited
into GenBank under Bioproject ID PRJNA261239 with the
accession number JXSV00000000, version JXSV01000000 with
53 contigs (Arivett et al., 2015). The draft genome of A118
(ST 404/ND) (AN: AEOW00000000) consist of 156 scaffolds
with a total length of 3,730,023 bp (Ramirez et al., 2011).
The genome has an average GC content of 38.4%, 88 tRNA
genes and 3,520 coding sequences were identified, of which
93.64% was annotated and manually curated using blastn results
(Traglia et al., 2014).
Data Collections for Comparative
Genomics
In order to perform accurate comparative genomics in
combination with experimental assays, we identified four groups
of genomes that were clustered to do our analysis (see below).
Global Clone 1 Group 1 (CC1/CC231) was composed by 18
genomes as follows: (i) A144 and A155 from Argentina (Vilacoba
et al., 2014; Arivett et al., 2015); (ii) 14 GC1 complete genomes
retrieved from GenBank which correspond to strains AYE (AN:
NC_010410.1), D36 (AN: CP012952.1), A1 (AN: CP010781.1),
AB307-0294 (AN: CP001172.2), AB5075-UW (AN: CP008706.1),
AB0057 (AN: CP001182.1), USA15 (AN: NZ_CP020595.1), A85
(AN: NZ_CP021782.1), A388 (AN: NZ_CP024418.1), AR_0083
(AN: NZ_CP027528.1), DA33382 (AN: NZ_CP030106.1),
9102 (AN: NZ_CP023029.1), 11W359501 (AN: CP041035.1),
NCTC13421 (AN: NZ_LS483472.1); and (iii) two highly quality
genomes available for GC1, strains NIPH 527 and NIPH 290,
isolated in 1984 and 1994, respectively (APQW00000000.1
and APRD00000000.1) (Table 1). Both GC1 strains, A144
and A155, were relevant for our country since they were
isolated in the 1990s when at that time clonal complex CC113
was predominant (Stietz et al., 2013). Therefore, A155 was
considered among the first GC1 isolates emerging in Argentina
(Ramírez et al., 2013) which is in agreement with the introduction
of carbapenems in our country (Vilacoba et al., 2014). This GC1
Group 1 of genomes include all GC1 complete genomes till
July, 2019 and they were used to perform the comparative
genomics for RGP, prophages, plasmids, CRISPR-Cas system,
Insertion Sequences (IS), Transposons, AbaR-types GI, and
genes encoding AdeABC, AdeIJK, and AdeFGH efflux pumps,
among others. The site of insertion of RGP, prophages, CRISPR-
Cas system, IS and AbaR-types GI, were identified for this
group, since most of these are complete genomes and allow
accurate identification.
Global Clone 1 Group 2 (CC1/CC231) was composed by 27
genomes as scaffolds and 61 genomes as contigs from GenBank
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TABLE 1 | General features of GC1 Group 1 and Outgroup Group 3 genomes.
Group Strain Country Year MLSTa GC GC1 lineage AbaR type intI1 in AbaR CRISPR
GC1 Group 1 A144 Argentina 1997 CC1/CC231 1 1 AbaR0-type Complete Yes
A155 Argentina 1994 CC1/CC231 1 1 AbaR0-type Complete Yes
A1 United Kingdom 1982 CC1/CC231 1 1 AbaR24 Complete Yes
AB307-0294 United States 1997 CC1/CC231 1 1 − − Yes
AYE France 2001 CC1/CC231 1 1 AbaR1 Complete Yes
AB0057 United States 2004 CC1/CC231 1 1 AbaR3 Deleted Yes
AB5075-UW United States 2008 CC1/CC231 1 1 AbaR11 − Yes
D36 Australia 2008 CC1/CC231 1 2 AbaR4 − Yes
USA15 South Korea 2013 CC1/CC231 1 1 AbaR10 − Yes
A85 Australia 2003 CC1/CC231 1 1 AbaR3 Complete Yes
A388 Greece 2002 CC1/CC231 1 1 AbaR28 Complete Yes
AR_0083 United States Unknown CC1/CC231 1 1 AbaR0-type Complete Yes
DA33382 Germany Unknown CC1/CC231 1 1 AbaR0-type Complete Yes
9102 Mexico 2010 CC1/CC231 1 1 − − Yes
11W359501 United Kingdom 2015 CC1/CC231 1 1 AbaR0-type Complete Yes
NCTC13421 United Kingdom 2004 CC1/CC231 1 1 AbaR0-type Complete Yes
NIPH 527 Netherlands 1984 CC1/CC231 1 1 AbaR21 Complete Yes
NIPH 290 Czechia 1994 CC1/CC231 1 1 AbaR0-type Complete Yes
Outgroup Group 3 ACICU Italy 2005 CC2/CC208 2 − AbaR2 Complete No
Naval-13 United States 2006 ST3/CC928 3 − AbaR4 − No
A118 Argentina 1995 ST404/* − − − − No
AB33405 Argentina 2013 CC79/CC113 − − AbaR4 − No
ATCC 17978 United States 1951 ST437/ST112 − − AbaR4 − No
aPasteur’s/Oxford’s MLST schemes; Clonal complexes (CCs) are numbered according to the most prevalent clone. STs are indicated when singletons. *The sequence
type (ST) was not found in Oxford’s MLST database.
(until July, 2019) that were identified as GC1 using the program
mlst2 which scans genome files against traditional PubMLST
typing schemes (Supplementary Table 1). The 88 genomes of
this GC1 Group 2 were used for searching RGP, genes encoding
AdeABC, AdeIJK, and AdeFGH efflux pumps, CRISPR-Cas
system as well as identification of K and OC locus in combination
with GC1 Group 1.
In summary, all GC1 genomes deposited in GenBank till July,
2019 were included in our analysis.
In order to identify exclusive accessory genome of GC1, we
clustered in the Outgroup Group 3 five genomes belonging
to other high-risk epidemic clones such as ACICU (AN:
CP000863.1) as representative of GC2, Naval-13 (AN:
AMDR01000001.1) as representative of GC3, AB33405
(NZ_JPXZ00000000.1;3) as representative of local epidemic
clone CC113 and both ATCC 17978 (AN: CP018664.1), and
A118 (AN: AEOW01000000) as sporadic clones (Table 1).
The Outgroup Group 4 was composed by 2407 genomes as
contigs and 549 genomes as scaffolds of A. baumannii that were
identified as non-GC1 using the program mlst2 (Supplementary
Table 1). The 2956 genomes of this group were downloaded from
GenBank (until August, 2019). The Outgroup Group 4 was used
to analyze if the CRISPR-Cas system identified in GC1 Group 1




Disk diffusion antibiotic susceptibility and/or minimal inhibitory
concentration tests were performed following the procedures
recommended by the CLSI (CLSI, 2018) with antimicrobial
commercial disks of ampicillin-sulbactam, sulbactam,
ceftazidime, cefepime, cefotaxime, imipenem, meropenem,
colistin, gentamicin, amikacin, minocycline, tetracycline,
ciprofloxacin, levofloxacin, trimethoprim-sulfamethoxazole,
rifampin, and chloramphenicol from Britania (Table 2).
When clinical breakpoints were not available from CLSI, only
the values obtained were shown. For sulbactam we used a
provisional susceptibility breakpoint of ≤4 µg/ml derived from
the CLSI breakpoint for ampicillin/sulbactam (≤8/4 µg/ml;
Krizova et al., 2013).
Comparison of AbaR Genomic Islands
Software ACT was used to compare AbaR islands
(Carver et al., 2005).
Phylogenetic Analysis
The core genome of the 18 genomes from GC1 Group 1
was calculated with GET_HOMOLOGUES software (Contreras-
Moreira and Vinuesa, 2013). Core genome SNPs were detected
using SNP-sites (Keane et al., 2016). SNP likely to have been
introduced together via a homologous recombination event were
detected and analyzed using Gubbins with default parameters
(Croucher et al., 2015). Phylogenetic tree was built using Gubbins
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TABLE 2 | Antimicrobial susceptibility profiles of strains under study.
Strain Susceptibility profiles Disk diffusion (mm)/MIC (µg/ml)
AMS SUL CAZ FEP CTX IPM MEM CL GEN AMK MIN TET CIP LEV SXT RIF CHL
A144 R −/16 R/32 I R/ ≥ 64 S S/2 −/S < 2 R/ ≥ 16 S/16 S R R/32 R R (12)/4 −/8
A155 R −/16 R/32 I R/ ≥ 64 S S/2 −/S < 2 R/ ≥ 16 S/16 S R R/32 R R (16)/4 −/8
A118 − −/4 − − − S S/1 − S/ ≤ 2 S − − S S − 4 −
ATCC 17978 − −/2 − − − − − − − − − − − − − 8 −
AMS, ampicillin-sulbactam; SUL, sulbactam; CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; IPM, imipenem; MEM, meropenem; CL, colistin; GEN, gentamicin; AMK,
amikacin; MIN, minocycline; TET, tetracycline; CIP, ciprofloxacin; LEV, levofloxacin; SXT, trimethoprim-sulfamethoxazole; RIF, rifampicin; CHL, chloramphenicol; R, resistant;
I, intermediate; S, susceptible. −, not determined. In the absence of CLSI 2018 interpretive breakpoint, the zone diameters are shown.
based on the alignment of the non-recombinant SNP obtained
and using a maximum-likelihood (ML) phylogeny inferred from
the alignment of these SNP. The five genomes from Outgroup
Group 3 were used as outgroup. The figure of the phylogenetic
tree was obtained using Evolview v3 (Subramanian et al., 2019).
Maintenance Studies of the AbaR
Genomic Islands
Strains A144 and A155 were grown each at 37◦C overnight
in 2 ml LB broth. Subcultures were carried out for 30 days
(Moffatt et al., 2010). At 1st, 7th, and 30th day, 30 colonies
were tested for presence of AbaR GI by PCR using two
pairs of specific primers that detect the disruption of the
gene comM, which target the junction with the 3′ATPase
(4R: 5′-AATCGATGCGGTCGAGTAAC-3′ and 4F: 5′-
TATCAGCAGCAAAACGATGG-3′) and the junction with the
5′ATPase (2R: 5′-TTGGGGATTCTGTCCGTAAG-3′ and 2F: 5′-
TCCATTTTACCGCCACTTTC-3′) (Shaikh et al., 2009; Ramírez
et al., 2013). The experiments were performed in triplicates.
In vitro Competition and Fitness
Measurements
A144 or A155 and A118 isolates were diluted to 1.6 × 108
(OD600 0.2) colony-forming units (CFU)/ml, equal volumes
were combined, thus the initial ratio of the isolate pairs was
close to 1:1, then 10 µl of the mixture was added to 20 ml
LB broth and grown at 37◦C with agitation at 200 rpm. At
24-h intervals, 10 µl of bacterial subcultures were transferred
to fresh LB broth; meanwhile, 10 µl was inoculated on MH
agar plates, and 10 µl on MH agar plates containing 16 µg/ml
gentamicin. CFU of A144 (resistant to gentamicin, Table 2) and
A118 (susceptible to gentamicin, Table 2) were counted, and
after 96 h, adaptive difference of each pair (A144/A118) was





) relative adaptive fitness as
F = 1+ S, and the fitness cost as C = (1− F) x100%, where S
is the selection coefficient and show the difference in fitness
between two competing strains at time t, rt = number of drug-
resistant colonies and st = number of drug-susceptible colonies,
rt−1 and st−1 are the number of drug-resistant and drug-
susceptible colonies at the preceding time point, respectively, and
the quotient of the ratios of the cell numbers was standardized
with 1/y, where “y” is the number of bacterial generations
during the assay (Sander et al., 2002; Guo et al., 2012; Li et al.,
2018). Here the exponent was 1/8 because cell numbers were
determined every eight generations. The terms rt/rt_1 and st/st_1
give the growth rates for drug-resistant and drug-susceptible
strains, respectively. Hence, S is the natural logarithm of the
quotient of the growth rates of the competing strains. S is positive
if resistance increases bacterial fitness compared to that of the
drug-susceptible competitor strain (Sander et al., 2002).
Statistical Analysis
Statistical analysis was performed with the software GraphPad
Prism version 8 using one-way analysis of variance (ANOVA).
P < 0.05 was considered to be statistically significant
(Li et al., 2018).
Detection of Regions of Genomic
Plasticity
As defined by Mathee et al. (2008) the minimum size of a region
of genomic plasticity (RGP) is defined as a block of at least
four contiguous ORFs that are not conserved in all strains from
a species. RGP were identified in GC1 Group 1 using RAST
(Aziz et al., 2008), in combination with Prokka (Seemann, 2014),
ISFinder (Siguier, 2006), PHASTER (Arndt et al., 2016), and
IslandViewer4 (Bertelli et al., 2017).
Mobilome and Resistome Analysis
Search of IS and transposons was done using ISFinder (Siguier,
2006) and blastn (Altschul et al., 1990) with a cut-off E-value
of E−10; genomic islands were predicted with IslandViewer4
(Bertelli et al., 2017) and phages with PHASTER (Arndt et al.,
2016). ARG were identified using RESfinder (Zankari et al., 2012)
and blastn (Altschul et al., 1990) with a cut-off E-value of E−10.
The ARG content previously reported was also included, when
required (Holt et al., 2016). BM4587 (AN: KR297239.1) was
taken as reference to compare the 7,591 bp comprising the adeL,
adeF, adeG, and adeH genes of the adeFGH efflux pump and its
regulator with a wild type expression level (Coyne et al., 2010).
The blaOXA-51-like genes were identified by Single-Locus-
Sequence-Based Typing (SBT) analyzing 825 bp (forward primer,
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5′-ATGAACATTAAAGCACTCTTAC-3′; reverse primer, 5′-
CTATAAAATACCTAATTGTTCT-3′) by blastn (Pournaras
et al., 2014). The ampC alleles were assigned using the database
hosted at the pubmlst platform for A. baumannii4 (Karah
et al., 2017). The blaTEM promoters were identified by blastn
(Lartigue et al., 2002). Mutations in rpoB were analyzed by
the comparison of the nucleotide sequences with the deduced
amino acid sequence of rpoB from Escherichia coli strain ATCC
8739 (ACA79637.1) and ACICU (YP_001844962.1) using blastn
(Giannouli et al., 2012). To determine the Quinolone Resistance-
Determining Regions (QRDR), the wild-type A. baumannii
GyrA (X82165) and ParC (X95819), QRDR GyrA81, ParC84, and
ParC88 were compared with those of E. coli at positions Ser-83,
Ser-84, and Glu-88, respectively (Ostrer et al., 2019).
Pangenome Calculation
The pangenome, the soft-core genome, and the core genome were
identified using the GET_HOMOLOGUES software (Contreras-
Moreira and Vinuesa, 2013) based on the GC1, GC2, GC3,
CC113, and sporadic clones genomes analyzed using a minimal
identity value of 70% and a minimal query coverage of 80%
sequence identity in blastn query/subject pairs.
Plasmid Recognition
Genes related to plasmids were identified mapping the A144 and
A155 contigs using the AYE strain genome as reference (AN:
CU459141.1) with MAUVE version 2.4.0 (Darling et al., 2004).
Contigs not mapping with AYE genome where blasted against the
non-redundant (nr) GenBank database with a cut-off E-value of
E−10 and analyzed for plasmid replicons.
Detection of Recombination Hotspots
Recombination hotspots (HS) are regions in a genome that
exhibit elevated rates of recombination relative to a neutral
expectation. Hotspots in the present study are associated with
both an increase in mutations in a region of the genome
and incorporation of accessory DNA. HS were identified using
the same methodology as in Touchon et al., 2014. The GC1
Group 1 core genome was used to identify and locate large
integration/deletion (indel) regions. All regions including more
than ten genes between two consecutive core genes of the
genomes were considered as large indel regions. The relative
positions of these regions were defined by the order of the core
genes in A. baumannii AYE. This strain was used as a reference
to assemble the GC1 Group 1 genes.
Identification of K and OC Loci
The exopolysaccharide loci were identified by blastn search for
the flanking genes (K: fkpA, lldP; OC: ilvE, aspS) as described
previously (Holt et al., 2016). Each locus was matched against
a set of known K loci or OC loci (Kenyon and Hall, 2013;
Holt et al., 2016).
4http://pubmlst.org/abaumannii/
CRISPR-Cas System Predictions
CRISPR were predicted using CRISPRfinder5 and CRISPRone6
using the default parameters.
RESULTS
Genomic Analysis of GC1 Strains From
H1 Hospital
Comparative genomics was carried out for A144 and A155 strains
from H1 Hospital with all GC1 Group 1 which were isolated from
four different continents (America, Oceania, Asia and Europe)
and with other epidemic and sporadic clones of the Outgroup
Group 3 genomes (Table 1). We found that A144 genome has
99% Average Nucleotide Identity (ANI) with A155 isolated from
the same hospital. Both A144 and A155 have 97% ANI with
GC1 Group 1 strains (Table 1). A144 and A155 exhibited 81%
ANI with ACICU (IC2), 83% with Naval-13 (IC3), and 79% with
AB33405 (GC113), A118 (sporadic clone), and also with ATCC
17978 (sporadic clone) of Outgroup Group 3 (Table 1).
We found that 2,840 genes were part of the core genome
comprising the 18 GC1 complete genomes under scrutiny. The
phylogenetic tree obtained with the non-recombinant SNPs
found in the core genes of the GC1 Group 1 genomes reflected the
two lineages previously reported (Holt et al., 2016), evidencing
that A144 and A155 genomes belonged to lineage 1 and they were
closely related to the strain AYE (Figure 1).
A difference of one order of magnitude was found when
analyzing the number of unique genes within the chromosomes
of GC1 (from 15 to 74 unique genes) when compared to GC2,
GC3, CC113, and sporadic clones (from 362 to 626 unique
genes). A144 contained 37 unique genes when we compared
its chromosome with GC1 Group 1 (Supplementary Table 2);
most of them were coding sequences of unknown function. Only
ten unique genes out of 37 had an assigned function, such as
two phage-related proteins, a copper resistance system oxidase
(copA), a zinc transporter (zitB), a cobalt transporter (czcD),
and two transcriptional regulatory proteins (qseB_2 and qseB_3)
that probably belong to a novel heavy metal resistance GI (Data
not shown). A155 contained sixteen unique genes not related
to pathogenicity or antimicrobial resistance (Supplementary
Table 2). The emergence of aac(6′)-Ian gene cassette was found
unique in AYE strain [94.13% aac(6′)-Ian allele (CP023420.1)].
The GC1 Group 1 possessed 39 unique genes compared to
Outgroup Group 3 that most of them were scattered in the
topology of the chromosome (Supplementary Table 2). For
example the array of the 6 cas genes (cas1-cas3-cas8f-cas5f-cas7f-
cas6f ) from the type IF-b CRISPR-Cas system that we found in
all GC1 genomes (GC1 Group 1 and 2) located in the same loci
in GC1 Group 1, a LysR_substrate_binding domain related to
LysR family of transcriptional regulators (ABAYE2346) that have
been identified that regulate a diverse set of genes, including those
involved in virulence, metabolism, quorum sensing and motility
(Maddocks and Oyston, 2008), three genes related to the lipid
5http://crispr.i2bc.paris-saclay.fr/Server/
6http://omics.informatics.indiana.edu/CRISPRone/
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metabolic process [coenzyme A (CoA) transferase (ABAYE2345),
acyl-CoA desaturase (ABAYE1343), and hydroxymethylglutaryl
CoA reductase (ABAYE2344)] among other genes that coded
for transferases, reductases, hydrolases and hypothetical proteins
(Supplementary Table 2).
Otherwise, we found that the Outgroup Group 3 ACICU,
A118, Naval-13, AB33405, and ATCC 17978 chromosomes had
358, 595, 412, 311, and 395 unique genes, respectively, when we
compared them with the pangenome of the GC1 Group 1, most
of them coding sequences of unknown function. The smaller
number of unique genes in GC1 could be related to the need of
balance among new genes putatively acquired by events of the
LGT and the genes of the core genome that may be necessary to
preserve synteny and/or functionality. Interestingly, in the case
of ATCC 17978, the previously described Tn6171 transposon of
49.9 kb length carrying a potential siderophore synthesis gene
cluster and transposition genes related to Tn7 (Hamidian et al.,
2015) without the typical invasion of a class 2 integron (Ramírez
et al., 2010) was found amongst the unique genes, evidencing its
independent acquisition by LGT events.
Comparative analysis between A144 and A155 chromosomes
revealed as expected that they had high degree of synteny
between them (Supplementary Figure 1). Besides, a high degree
of synteny among all GC1 Group 1 genomes was found
including D36, which belongs to another lineage within GC1
epidemic clone (Supplementary Figure 1). Four regions related
to hotspots (HS) (see below) disrupted synteny among GC1
chromosomes; at loci ABAYE1410 to ABAYE1438, ABAYE2053
to ABAYE2054, ABAYE2822 to ABAYE3048 and ABAYE3550 to
ABAYE3552 in AYE genome; these regions also showed signs
of microevolution identified as Regions of Genomic Plasticity
(RGP) RGP2/HS8, RGP3/HS12, RGP5 and RGP6 with HS15
and HS16, and RGP7/HS18 that corresponded to AbaR genomic
island, respectively (Figure 2) (see below).
Comparative Analysis of the Resistome
of GC1 Genomes
The resistome analysis was carried out in detail for A144
and A155 strains compared with GC1 Group 1 and with the
epidemic and sporadic clones of the Outgroup Group 3 genomes
(Figure 1, Table 1, and Supplementary Table 3). We found
that A144 and A155 showed a multidrug resistant phenotype
as defined by Magiorakos et al. (2012) that was in concordance
with the findings of antimicrobial resistance determinants by
bioinformatics tools (Table 2, and Supplementary Table 3).
FIGURE 1 | Molecular phylogenetic analysis and antimicrobial resistance determinants of GC1 Group 1 and Outgroup Group 3. The evolutionary history was inferred
by using the Maximum Likelihood method based on the General Time Reversible model. The inset legend indicates the genetic determinants highlighted. When
required, blastn was used with a cut-off E-value of E−10.
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FIGURE 2 | Prediction of elements of the accessory genomes identified in GC1 Group 1 genomes from this study. Genetic and physical map of GC1 chromosomes.
The inner black circle belongs to A144 chromosome and the inset legend indicates the remaining GC1 Group1 chromosomes. The outer legend corresponds to
RGP, bla genes, the three efflux pumps and CRIPSR/Cas found in the eighteen GC1 Group 1 genomes in the same loci, indicated with black letters and lines is also
shown in the outer circle. The hot spots (HS), RGP, and prophages found in A144 are shown in red letters and lines. Black histogram represents CG content of A144
strain. Regions related to some hotspots (HS) disrupted synteny among GC1 chromosomes which also corresponded to RGP in A144 as follows, RGP2/HS8
(JQSF01000083.1: 1-33700 and JQSF01000082.1: 24920-27366), RGP3/HS12 (JQSF01000043.1: 1 -38248 and JQSF01000071.1: 12398-14538), RGP5/HS15
together with RGP6/HS16 (JQSF01000080.1: 153-15902, JQSF01000022.1, JQSF01000055.1, JQSF01000037.1, JQSF01000003.1, QSF01000040.1,
JQSF01000042.1, JQSF01000065.1 and JQSF01000041.1: 1-20291), and RGP7/HS18 that corresponded to AbaR GI (JQSF01000053.1: 1-8092,
JQSF01000058.1, JQSF01000063.1: 797-1612, JQSF01000054.1: 253-2358, JQSF01000030.1: 448-21672, and JQSF01000084.1: 23-13490).
Both strains harbored almost the same ARG usually associated
with the core genome (i.e., blaOXA−51−like and ampC) as well
as those acquired by LGT events, but A144 had two copies
instead of one of the rifampicin resistance rpoB gene as well
as for the tetracycline resistance tet(A) gene, and one copy
of the chloramphenicol resistance catA1 gene (Supplementary
Table 3). The only phenotypic difference related to the presence
of these extra genes was a reduced zone diameter for rifampicin in
A144 but maintaining the same low MIC (Table 2). Neither A144
nor A155 showed acquired ARG for colistin, fluoroquinolones,
trimethoprim, fosfomycin, fusidic acid, glycopeptides, nor
rifampicin (Supplementary Table 3).
In regard to the β-lactams resistance genes, the naturally
harbored blaOXA−51−like and ampC alleles identified in the GC1
Group 1 genomes were different from those found in the other
clones from Outgroup Group 3 (Supplementary Table 3). The
blaOXA−69 allele (AY458016) was conserved in 17/18 GC1 Group
1 genomes and the remaining strain A388 contained blaOXA−92
(WP_059262713.1), in agreement with previous finding of
Pournaras et al. (2014). In AYE, blaOXA−69 was downstream of
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ISAba1, which was related to increase β-lactam resistance (Chen
et al., 2010). It was not the case for A144 nor A155 which
could be in part related to their susceptibility to carbapemens.
Analysis of ampC showed that A144 and A155 harbored a
same novel allele with no IS upstream. A wide variety of ampC
alleles were in the GC1 Group 1 (mostly alleles 1 and 8) and
Outgroup Group 3. The ISAba1 and ISAba125 were upstream of
ampC in both groups, with no apparent preference for any allele
(Supplementary Table 3).
We found four blaTEM alleles in 8/18 GC1 Group 1 genomes
and only one blaTEM−1−like allele with the P3 promoter in
the Outgroup Group 3. We identified that A144 and A155
are resistant to sulbactam and harbored blaTEM−1 with the
Pa/Pb promoters (Table 2, and Supplementary Table 3), which
had been shown to exhibit higher strength when compared
to P3 (Lartigue et al., 2002; Krizova et al., 2013). Our results
suggest that blaTEM−1 in A144 and A155 with the Pa/Pb
promoters could be involved in the increase of the sulbactam
MIC (Table 2). The other three different alleles in GC1
Group 1 genomes were blaTEM−19−like with P3, which is the
weakest promoter and was related to sulbactam susceptibility
(Lartigue et al., 2002; Krizova et al., 2013). The other β-lactams
resistance genes that we detected in GC1 Group 1 genomes
were blaOXA−10 (1/18), blaOXA−23 (7/18), blaOXA−235 (1/18
with 5 copies), blaVEB−1 (1/18), blaGES (1/18), blaPER−7 (1/18),
and blaNDM−1 (1/18). Of those, we also found blaOXA−23 in
Outgroup Group 3.
Regarding rifampicin resistance genes, we detected the
acquired ARG arr-2 in two (2/18) GC1 Group 1 genomes and
it was absent in Outgroup Group 3 (Supplementary Table 3).
A144 was the only strain studied that harbored two copies
of the most common rpoB allele (Giannouli et al., 2012).
Two other GC1 Group 1 genomes and two from Outgroup
Group 3 had different alleles of rpoB (Supplementary Table 3).
Concerning the fluoroquinolone resistance, we found that the
Plasmid Mediated Quinolone Resistance genes (PMQR) were
absent in the GC1 Group 1 genomes and the Outgroup Group
3. Noteworthy, we detected the mutations in the QRDR of gyrA
and parC enough to predict fluoroquinolone resistance (Ostrer
et al., 2019), specifically for ciprofloxacin resistance (GyrA81)
in 15 (15/18) and for ciprofloxacin plus levofloxacin (GyrA81-
ParC84) in A144 and A155 together with others (11/18) in GC1
Group 1, but only in two and one genomes of Outgroup Group 3
(Supplementary Table 3).
The acquired aminoglycoside resistance genes that we
identified in A144 and A155 were the aac(6′)-Ib3 gene cassette
located in a class 1 integron within the AbaR GI, and 1aac(3)-IIa
and aph(3′)-Ia located in transposons (Vliegenthart et al., 1989;
Arduino et al., 2012) (AN: X60321, X51534, X62115, respectively;
Supplementary Table 3). The respective 1aac(3)-IIa genes from
A144 and A155 lacked the last 59 bp of the 3′ end of the
gene, and they were adjacent to blaTEM−1 surrounded by IS26
as previously described in plasmid pAB35063_a (MK323042.1)
(Supplementary Table 4). In total, 14 (14/18) GC1 Group
1 genomes and two in Outgroup Group 3 showed at least
one acquired aminoglycoside resistance gene (Supplementary
Table 3). A deeper analysis of aph(3′)-Ia revealed that the same
variant surrounded by IS26 and IS15DI was also found in AYE,
AB0057, A85, A388, AR_0083, DA33382, NCTC 13421 and
NIPH527 GC1 Group 1 genomes at the same locus in A144
and A155 genomes.
Regarding sulfonamide resistance, we detected sul1 in 15
(15/18) and sul2 in 4/18 GC1 Group 1 genomes (Supplementary
Table 3). In A144 and A155, sul1 was within a class 1 integron.
The tetracycline resistance genes tet(A) (11/18) and tet(G)
(1/18) were identified only in GC1 Group 1 genomes.
The phenicol resistance gene catA1 was found in eight GC1
Group genomes with 99.85% of identity compared to the one
identified in A144 (Supplementary Table 3).
The cmlA, dfr and genes related to macrolides, lincosamides
and streptogramines resistance (MLS), the mph(E) and msr(E)
genes were found in some GC1 Group 1 and Outgroup
Group 3 while they were not detected in A144 nor in A155
(Supplementary Table 3).
Moreover, the presence of class 1 and class 2 integrons was
analyzed. The intI1 gene was identified in 13 out of 18 GC1 Group
1 genomes and in a total of 56 from the 106 genomes of GC1
Groups 1 and 2 (Figure 1, and Supplementary Tables 3, 5). The
intI2 gene was found in seven out of the 106 genomes of GC1
Groups 1 and 2, of which only strain AR_0083 was from GC1
Group 1 (Figure 1, and Supplementary Tables 3, 5).
The relevance of three resistance-nodulation-cell division-
type efflux pumps (AdeABC, AdeIJK, and AdeFGH; Figure 3)
in antimicrobial resistance in A. baumannii has been highlighted
(Marchand et al., 2004; Fournier et al., 2006; Coyne et al.,
2010, 2011; Rosenfeld et al., 2012). Here, we investigated their
variability in GC1. We found that A144 and A155 shared
the same alleles for the three efflux pumps and that all GC1
Group 1 and Group 2 genomes contained these three efflux
pumps with different levels of identity for each gene (Figure 1,
and Supplementary Tables 3, 6). The complete AdeABC efflux
pump genetic structure includes the adeA, adeB, adeC and
their regulatory genes, which encode the two-component system
FIGURE 3 | Genetic organization of the AdeFGH, AdeFGH and AdeIJK RND
efflux pumps and their regulatory genes. Reference sequences: adeABC and
adeRS, NC_010410.1 (coordinates 1883328-1891105); adeFGH and adeL,
KR297239.1; adeIJK and adeN, CP000521.1 (coordinates
3171871-3177761 to 2292697-2293350).
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AdeRS (adeR and adeS) (Coyne et al., 2010). None of the
adeR or adeS alleles exhibited the T153M or P116L mutations
previously associated with an MDR phenotype in the 106 GC1
genomes (Marchand et al., 2004; Fournier et al., 2006). The
adeABC and adeRS genes were surrounded by ABAYE1818
and ABAYE1824 which encoded hypothetical proteins in AYE.
This genetic context was in 17 out of the 18 GC1 Group 1
genomes, except in strain 9102, where ABAYE1818 was also
lost together with part of the efflux pump genes described
above. Apart from the difference in this last strain, the other
GC1 Group 1 genomes contained these genes in the same
location as a module; in the case of D36 invasion of ISAba1 was
identified between adeR and adeA suggesting a recent acquisition.
Interestingly, from the Outgroup Group 4 comprising 2956 non-
GC1 draft genomes, adeC was absent in 615 draft genomes;
even 64 draft genomes lacked the complete adeABCRS genes
(Supplementary Table 6). Concerning the adeFGH efflux pump
genes and the adeL regulator (Coyne et al., 2010), we found
they were within the same loci surrounded by ABAYE1169
and ABAYE1178 which encoded a putative exported protein
and a histidine transport system permease protein, respectively.
The four genes related to this efflux pump were present in
the 106 G1 Group 1 and 2 and also in Outgroup Group
3 genomes, except for Naval-13 and A118 (Figure 1, and
Supplementary Tables 3, 6). From the 2956 non-GC1 draft
genomes of the GC1 Outgroup Group 4, adeFGHL genes were
absent in 2 genomes (Supplementary Table 6). The third
efflux pump analyzed in this study was the adeIJK efflux
system which is controlled by a TetR regulator namely adeN
(Coyne et al., 2010, 2011). GC1 Group 1 genomes showed
the adeN gene without insertions, and they shared the same
allele with 11SNP compared to CP000521.1 except both A144
and A155 which had an extra point mutation (Supplementary
Table 3). It was reported previously that the ISAba1 disruption
of adeN in A. baumannii PKAB07 eliminated the adeN
repression of AdeIJK triggering uncontrolled expression of
genes of the adeIJK operon (Rosenfeld et al., 2012); this
event was not found in GC1 Group 1 and 2 genomes. We
also observed that in GC1 Group 1 the adeIJK efflux pump
module was located in the same genetic context flanked by
ABAYE0745 and ABAYE0749, as well as the adeN regulator
gene surrounded by ABAYE1571 and ABAYE1573. Amongst
the 2956 non-GC1 draft genomes of the GC1 Outgroup Group
4, the adeIJK genes were not complete in 3 genomes, while
its regulator gene, adeN, was not identified in ten genomes
(Supplementary Table 6).
Noteworthy, adeA and adeI were the only genes that showed
100% identity in GC1 Group 1 and 2, with the exception for
adeA and adeRS genes that were deleted or lost in strain 9102,
respectively, probably due to genetic rearrangements (Figure 1,
and Supplementary Tables 3, 6). Unlike the other genomes
studied here from GC1 Group 1 and 2 and Outgroup Group
3, Naval-13 and A118 lacked the 3 major resistance-nodulation-
cell division-type efflux pumps of A. baumannii as well as their
regulators (Figure 1, and Supplementary Tables 3, 6). Most non-
GC1 from Outgroup Group 3 suffered the loss of different ade
features (Figure 1, and Supplementary Table 3).
The 106 GC1 genomes from Groups 1 and 2 maintained intact
the three efflux pumps, except for the partial deletion of adeABC
efflux pump in strain 9102 (Supplementary Tables 3, 6). As a
whole the deep analysis of the three resistance-nodulation-cell
division-type efflux pumps in A. baumannii revealed that the
deletion and loss of some genes affected non-GC1 genomes at
different extents, evidencing events of genomic loss mostly in the
adeABC efflux pump.
Mobile Genetic Elements Found in GC1
Strains
A wide variety of mobile genetic elements (MGE) associated
with the mobilome were identified in GC1 Group 1. We found
that the type and the copy number of the IS varied among
all the genomes of GC1 Group 1. A144 and A155 shared
IS1R, IS6100, ISPpu12, IS26 or IS15DI (not possible to specify
with the sequence available data), and Tn3; in A144 we also
identified ten ISAba125, five IS26, while in A155 we detected
three ISAba125, and one ISAba125-related (Supplementary
Table 7). It is interesting to note that in A144 we identified
a deletion of 1,521 bp within the AbaR GI compared to
AYE and AB0057 which resulted in the loss of the 5′ end
of a transposase (ABAYE3582) adjacent to an IS26, rendering
a structure compatible to IS26/IS15DI-tnpR-1tnp-IS26 (AN:
JQSF01000054.1). This arrangement was absent in other genomes
of the GC1 Groups 1 and 2. A144, A155, AYE, A1, AB0057, A85,
NIPH 527, and NIPH 290 shared four IS (IS1R, IS26, IS6100
and ISPpu12-related) with different degree of identity among the
genomes (from 97 to 100%), which belong to the IS families IS1,
IS6, and ISL3, respectively. Most IS copies were found at different
loci (Supplementary Table 7).
The IS6100 found in A144, A155, AYE, A1, AB0057, A85,
A388, 11W359501, NIPH 527, and NIPH 290 genomes was
located within the same loci in the AbaR GI close to a mer
module (merA, merC, merD, merE, merP, merR, merT genes)
between ABAYE3607 and ABAYE3610. In addition, this IS was
found related to indels from one side and different insertions
or inversions on the other side. IS6100 was found inverted
in A144 and A155 when compared to AYE, evidencing events
of microevolution.
As expected, IS26 and ISPpu12-related that are usually find
within the AbaR0-type GI were detected in 14 and 15 out of 18
of GC1 genomes, respectively, evidencing that their absence in
some strains was related to genomic reduction or to the absence
of the AbaR0-type GI (see below) (Supplementary Table 7).
While six IS (ISAba125, ISAba1, ISAba2, ISAba12, IS26, and
ISPpu12) were shared by GC1 Group 1 and Outgroup Group 3,
16 IS (IS1R, ISaba10, ISAba26, ISAba14, IS10A, IS18, ISaba13,
IS15DI, IS15DII, IS6100, IS1396, Tn3, IS1006, ISVsa3, ISEc29,
and ISEc28) were detected solely in GC1 Group 1 isolates
(Supplementary Table 7). On the contrary, three IS identified
in Outgroup Group 3 (ISAba18, IS17 and ISAba11) were not
detected in GC1 Group 1 nor in Group 2 draft genomes,
while ISVsa3 was the only identified in Outgroup Group 3
which was not detected in GC1 Group 1 but in Group 2
draft genomes (7/106). It was curious that AB307-0294 (GC1,
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Lineage 1) and A118 (sporadic clone) did not harbor any IS
(Supplementary Tables 7, 8). These results suggest that although
IS may be relevant in most strains, they are not essential for
A. baumannii survival.
With our set of genomes, prophage analysis showed
that the strains from GC1 Group 1 had 11 different
putative prophages (Table 3, and Supplementary Figure 2).
Interestingly, one of these prophages, the putative prophage
YMC/09/02/B1251_ABA_BP (AN: NC_019541.1) was found
complete in A144 and with variable lengths in the remaining
17 GC1 genomes assessed including A155 (Table 3). A144
contained a second deleted copy of this prophage (Table 3). We
searched for this prophage in GC1 Group 2 and Outgroup Group
3. We found several complete and incomplete copies in every
genome of the 88 A. baumannii strains from GC1 Group 2 (Data
not shown). Four out of five genomes from the Outgroup Group
3 has at least one copy of this prophage (Table 3), evidencing its
wide dissemination not only in GC1 but also in several clones
of A. baumannii. When we investigated the sites of insertion of
the prophage YMC/09/02/B1251_ABA_BP in GC1 Group 1, we
found several locations except three patterns for some genomes.
In AYE, D36, AR_0083, and 9102 the prophage was flanked by
the same genes, a cell division gene zapA (ABAYE2682) and
the 23S rRNA (ABAYE2761) gene (Supplementary Table 9).
In one of the prophages found in A155, as well as in AB307-
0294, the prophage was flanked by the same cell division gene
zapA (ABAYE2682) and gdhA_2 gene (ABBFA_02560 locus
from AB307-0294) (Supplementary Table 9). Thirdly, in A1,
AB0057 and A85 the prophage was flanked by the same genes
aroP (ABA1_03000) and chaperone hsp31 gene (ABA1_03077)
(Supplementary Table 9). In the case of A144, the prophage
was flanked by a putative signal peptide (ABAYE2757) and
the same chaperone hsp31 gene (ABA1_03077). Interestingly
both copies of the prophage in A144 and A155 have different
insertion sites (Supplementary Table X9), evidencing a
trade-off between maintenance of this prophage probably
acquired before diversification of GC1, and great processes
of microevolution, deletions and insertions. Previously, it has
been described the dissemination of Acinetobacter ACICU
prophage 3 in 151 genomes of A. baumannii (Chan et al.,
2015). When we searched for prophage 3 in GC1 Group 1
and 3, we found that it was not detected in A144 nor in
A155 but present with different lengths in D36, AB0057, A85,
A388, DA33382, 11W359501, NCTC13421, and NIPH 290
genomes (Table 3).
Also, a total of 27 plasmids were found in thirteen out of
the eighteen GC1 Group 1 genomes (Supplementary Table 4).
AB307-0294, 11W359501, NCTC13421, NIPH 527 and NIPH
290 strains did not harbor any plasmid or replicon. The search
of replication initiation proteins previously described (Carattoli
et al., 2014; Hamidian and Hall, 2018a; Salto et al., 2018),
revealed the predominance of the Rep_3 superfamily (17/27)
in the GC1 Group 1 genomes (Supplementary Table 4). It
was not possible to identify any replicases in eight replicons,
suggesting that they may have other replication mechanisms as
previously found in other A. baumannii isolates (Salto et al.,
2018). The putative plasmids from A144 and A155 had 100%
TABLE 3 | Prophages found in GC1 Group 1 and outgroup group 3 genomes.













A85 22,275; 57,891; 52,826
A388 56,058; 23,332
AR_0083 53,135; 56,637
DA33382 27,147; 58,967; 49,779
9102 56,197
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TABLE 3 | Continued
Phage Strain Size (bp)














Enterobacteria phage mEp235 (NC_019708.1) AB33405 44,800
Erwinia vB_EamM_ChrisDB (NC_031126.1) AB33405 7,300
of query cover and 100% identity with rep_3 from pIH18,
which has been recently identified in nosocomial A. baumannii
isolates from Argentina (Salto et al., 2018). The rep_3 replicase
related genes were also spreading in GC1 Group 3 genomes. The
RepAci1 that also belongs to Rep_3 Superfamily (ALJ89812.1)
was identified in several GC1 plasmids around the world
but not in A144 and A155 nor in a previous study from
Argentina (Salto et al., 2018) evidencing a different pattern of
plasmid dissemination.
Plasmids or putative extrachromosomal replicons ranged
from 1,967 bp (p3AB5075, NZ_CP008709.1) to 98,301 bp
(pUSA15_1, NZ_CP020594.1). Ten out of the 27 plasmids or
putative extra chromosomal replicons carried ARG, whereas
p1AB5075 (NZ_CP008707.1) and pD36-2 (NZ_CP012954.1)
possessed class 1 integrons with different gene cassettes
arrays (Supplementary Table 4). Several IS such as ISAba125,
ISAba2, ISAba3, ISAba5, IS1, IS6, IS30, ISL3, Tn4352:ISAba1,
Tn501/Tn1696, and ISAba32 were found in eight plasmids which
have related sequences to rep_3 gene (Supplementary Table 4),
evidencing the important role of this family of replicases for
the acquisition of IS due to the flux of plasmids by events of
LGT by GC1 strains.
Genomic Analysis and Maintenance
Along Time of the AbaR0-Type Genomic
Island Identified in A144 and A155 Strains
Sixteen out of eighteen GC1 genomes harbored an AbaR
GI inserted in the comM gene, except AB307-0294 (Holt
et al., 2016) and 9102 that possessed a complete comM gene.
A144 and A155 genomes contained an AbaR0-type backbone
GI, with the typical complete intI1 gene (Hamidian et al.,
2016). The remaining GC1 Group 1 strains from lineage 1
carried AbaR0 or AbaR3-types GIs (Hamidian et al., 2014;
Holt et al., 2016; Hamidian and Hall, 2018b). Many of them
showed deletions in their structure caused by IS26 (Data not
shown), probably due to either recombination events between
duplicate copies of sul1 or Tn6018, or by gene cassette addition
or replacement as previously described (Holt et al., 2016;
Hamidian and Hall, 2018b).
The AbaR0-type GI from A144 contained all the core modules,
including Tn1721/Tn21, Tn1000-like, Tn5393, Tn6020 and Tn21
(Figure 4). In addition, it harbored the transposon Tn2760 found
in AbaR3, but lacked transposon Tn2. We also found a variant of
multidrug-resistance regions described previously with a change
in the module of the Tn1696 transposon, which presented two
copies of mer genes flanking the IS6100 sequence (Figure 4). The
class 1 integron found in A144 and A155 had the genetic platform
IS26-Tn21-intI1-aac(6′)-Ib-qacE11-sul1-orf5. The presence of
aac(6′)-Ib within the variable region of a class 1 integron in an
AbaR0-type GI is unusual since it commonly contains the array
aacC1-orfP-orfP-orfQ-aadA1 (Kochar et al., 2012; Hamidian and
Hall, 2018b). Downstream of orf5 we found the genes resX
and trbI, as previously described (Kochar et al., 2012). As a
difference with A144, the AbaR0-type GI from A155 lacked the
module carrying both mer operons and Tn6018-R (Figure 4).
The maintenance of the AbaR0-type GI from A144 and A155
strains in the absence of antibiotic pressure was evaluated in three
independent experiments after serial subcultures for 30 days by
PCR using specific primers for detecting an invasion at the comM
gene. No loss of the AbaR0-type GI from A144 nor A155 genomes
was observed. This experiment evidenced that this GI was stable
throughout time at least over one month.
We further analyzed the attI1 sites of the class 1 integrons
found in the GI of A144 (JQSF01000046.1, contig 2 coordinates
1992-2068) and A155 (JXSV01000033.1, contig 33 coordinates
1933-1857). Both recombination sites were identical to each other
and surprisingly to only one attI1 site when compared to those
found in AYE. Three complete class 1 integrons in the AbaR1-
type GI had been described in AYE strain (Fournier et al., 2006).
When doing this study, we identified a fourth attI1 site with a
deleted intI1 gene (see below). Interestingly, the four attI1 sites
harbored different variants (Figure 5). We found the typical attI1
site, that we referred here as variant 1 in the class 1 integron
that harbored the dfrA1 gene cassette in the variable region.
The variant 2 was found in the attI1 site associated to the gene
encoding a fusion protein GroEL/intI1, with the blaVEB−1–aadB-
arr-2-cmlA5-blaOXA−10-aadA1 gene cassette array. This attI1
variant was invaded by the IS1999, which additionally generated
a 9 bp duplication. The third class 1 integron contained the
variant 3 of the attI1 site and the aacC1-orfP-orfP-orfQ-aadA1
gene cassette array; this variant showed 100% identity with that
found in the GI of A144 and A155. This variant contained the
insertion of 19 bp in tandem (Wohlleben et al., 1989) at positions
-24 and -23 of the typical attI1 site and it was also found in
11 out of 18 GC1 Group 1 genomes (A144, A155, AYE, A1,
AB0057, A85, A388, DA33382, 11W359501, NCTC13421, and
NIPH 290) and in 59 genomes from GC1 Group 2, showing that
it was present in at least 66% genomes of this clone (70/106).
The GCF_003325575.1_ASM332557v1 genome was the only one
from GC1 with two copies of this variant. Also, this attI1 variant
was present in ACICU from Outgroup Group 3 genomes (1/5)
and in 1,104 genomes (1,104/2956, 31 of which harbored up
to three copies of this variant) in Outgroup Group 4 (data not
shown). Finally, the fourth attI1 site in AYE that we identified
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FIGURE 4 | Representation of the AbaR0-like GI found in Acinetobacter baumannii AYE, A144 and A155 strains. The comM gene is interrupted by the insertion of
the AbaR0-like GI. The region of multidrug resistance (MARR) is detailed, in this area we found variations in relation with the AbaR type GI previously reported.
in this work was the variant 4, which showed a deletion at the
3′ end of the attI1 site, from position-16 to the end of the site
(Figure 5) linked to a second GroEL/intI1 fusion that contains
the first 301 bp of the intI1 gene. This deleted class 1 integron
possesses the aac(6′)-Ian gene cassette in the variable region that
we have previously found as unique gene in AYE compared to
other GC1 Group 1 and 2 genomes. It is likely that the novel gene
cassette aac(6′)-Ian has been acquired by variant 4 of the attI1
site due to an active IntI1 provided in trans by other complete
intI1 genes.
Genomic Diversification by LGT of GC1
Strains
Since A. baumannii has a large pangenome with diverse gene
traits that suggests frequent LGT events, we evaluated the
presence of RGP including GI, and their potential association
with hotspots of recombination (HS) as defined previously (see
Materials and Methods). Seven RGP were identified in A144.
Two of them, the RGP1 and RGP4 were detected in the 106 GC1
Group 1 and 2 genomes but the Outgroup Group 3 (Table 4, and
Supplementary Table 6). Interestingly, six of them were found in
A155 (RGP1, 2, 3, 4, 6, and 7) and four of them were found in
AYE (RGP1, 4, 6, and 7).
The RGP1 harbored a block of 29 genes related to LSU and
SSU ribosome proteins (ABAYE0406-ABAYE0434) and its G+C
content (43%) differed from the average content of A. baumannii
GC1 strains (39%). GC1 Groups 1 and 2 harbored the RGP1
with 100% of query cover and most of them with more than
99.96% identity (Table 4, and Supplementary Table 6). The
RGP4 contained 8 genes (ABAYE2146-ABAYE2153); one of them
was related to a phage integrase gene, and another was a putative
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FIGURE 5 | Comparison of the attI1 recombination sites found in the GI of A144, A155 and AYE. The variant 1 is the typical attI1 site. Variant 2 shows the insertion
of the IS1999 and a 9 bp duplication of a portion of the attI1 site. Variant 3 found in the three genomes, shows a 19 bp duplication. Variant 4 has a deletion of the 3′
end of the attI1 site. The characteristic regions of the attI1 site are marked as follows: Direct Repeat 2 (DR2), broken-line arrow; Direct Repeat 1 (DR1), double-line
arrow; simple site, horizontal line; Shine-Dalgarno (SD) sequence identified for the orf-11, stars. The predicted sequence of the orf-11 is shown. The duplications are
depicted in boxes. The gene cassette next to each attI1 variant is indicated and the corresponding initial nucleotides are shown in lower case. The sequences of the
variants 1 to 4 of the attI1 site found in AYE correspond to the following coordinates in CU459141.1: 3.677.401-3.677.465 bp, 3.661.663-3.663.064 bp,
3.624.336-3.624.419 bp and 3.668.061-3.68.101 bp, respectively.
repressor related to the TetR family (TetR) which are genes that
code for proteins playing an important role in the regulation
of tetracycline resistance and other functions (Supplementary
Table 10; Ramos et al., 2005; Saranathan et al., 2017). The 106
GC1 genomes harbored the RGP4 usually with more than 97.25%
of query cover and most of them with more than 99.98% identity,
evidencing as well as RGP1 a high nucleotide conservation
among GC1 members (Supplementary Table 6). Twenty-seven
RGP1 and 34 RGP4 were also found in other non-GC1 genomes
from A. baumannii Outgroup Group 4 with 100% query cover
and identity (Supplementary Table 6).
Besides the previously described AbaR0-type GI, which
corresponded to RGP7, three out of seven RGPs were detected
as GI by bioinformatics analysis (RGP2, RGP3, and RGP5)
(Table 4). These three RGP also contained putative phages
denoting a potential DNA mobilization to other strains. RGP2
was identified in A144, A155, USA15 and AR_0083 strains while
RGP3 was identified only in A144 and A155 (Figure 2). A144
and A155 contained phage Mannheimia vB_MhM_3927AP2
(AN: NC_028766.1) in RGP2 and phage Bordetella BPP-1 (AN:
NC_005357.1) was identified in RGP3. A144 and D36 also
shared RGP5 (Table 4), which contained phage Acinetobacter
YMC/09/02/B1251_ABA_BP (AN: NC_019541.1). Lastly, RGP6
in A144 contained six genes including two coding for Phage T7
exclusion proteins.
On the other hand, it has been previously identified 78
hotspots of recombination (HS) in A. baumannii genomes
belonging to several lineages (Touchon et al., 2014). Here, we
identified 19 HS of recombination along the core-genome of
GC1 Group 1 strains using AYE as reference (Figure 6). As
previously reported, a concentration of hotspots closer to the
terminus of replication and symmetrically distributed around
this position (Bobay et al., 2013; Touchon et al., 2014), was also
observed in GC1 Group 1 genomes from our study (Figure 6).
At the same time, GC1 chromosomes have regions with no
signs of genome plasticity suggesting that they are less plastic
(Figure 6). Interestingly, some hotspots were related to RGP
such as the case of RGP6 (ABAYE2883-ABAYE2888) which
contained a 3′-5′ ssDNA/RNA exonuclease gene, a queC_2
7-cyano-7-deazaguanine synthase gene and four hypothetical
proteins in A144 corresponding to HS16, and RGP7 which
harbors the AbaR0-type GI, corresponding to HS18, evidencing
association with LGT events (Figure 6). HS1 in AYE and AB5075-
UW was also associated with LGT events since phage related





















TABLE 4 | RGP found in A144 when compared with the CG1 Group 1 genomes.
RGP Description # Genes A144 AYE A155 AB307-0294 AB0057 D36 A1 AB5075-UW USA15



































































Not found Not found Not found Not found AN415_RS13755-
AN415_RS13805
Not found Not found B7L41_RS14855-
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RGP Description # Genes A85 A388 AR_0083 DA33382 9102 11W359501 NCTC13421 Phage found in RGP
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FIGURE 6 | Distribution of hotspots along the core-genome of Acinetobacter baumannii GC1 Group 1 genomes. The gene order of A. baumannii AYE strain was
used as a reference (see section “Materials and Methods”). The bars represent the number of different gene families in all the genomes found between two
consecutive genes of the core-genome of GC1 genomes.
genes were found inserted within the two core genes. HS2
also encoded phage related proteins in D36 and was inserted
within two core genes. HS3 to HS6, HS14 and HS15 possessed
genes coding for hypothetical proteins; HS7 in AB5075-UW
encoded a site-specific integrase, one IS256 and also a phage-
related protein; HS10 in AYE had the transposase ISAba1;
HS11 and HS13 had phage-related genes; and HS17 in AYE
had copC and copD genes that belong to a diverse group
of periplasmic copper binding proteins. Lastly, as previously
detected by Holt et al. (2016), HS19 was found within genes
coding for the biosynthesis of exopolysaccharides via the K
locus. When we investigated deeply the variability in K locus
in our set of 106 genomes from GC1 Group 1 and 2, we
found ten gene clusters of K locus (KL1, KL4, KL9, KL12,
KL15, KL17, KL20, KL25, KL40 and KL42) with 100% of query
cover and more than 97% of identity, and five gene clusters
for OC locus (OCL1, OCL2, OCL3, OCL4 and OCL5) which
were already described by Holt et al. (2016, Supplementary
Table 8). The KL1 locus (31/106) was prevalent amongst GC1
genomes in both lineages (Supplementary Table 11). The OC
locus was absent in 9102 (NZ_CP023029.1) complete genome
(Supplementary Table 11).
Identification of Adaptive Immune
Systems in GC1 Genomes
We also looked for Clustered Regularly Interspaced Short
Palindromic Repeats and their associated Cas proteins (CRISPR-
Cas systems). These elements can provide host immunity against
bacteriophages and plasmids (Shmakov et al., 2017), which are
commonly associated to LGT events (Di Nocera et al., 2011;
Touchon et al., 2014). Previously it has been reported that
most CRISPR-Cas systems found in the genus Acinetobacter
corresponded to type I-Fa or Fb elements, where type I-Fb was
highly spread in different clonal complexes with a significant
vertical evolution including GC1 (Hauck et al., 2012; Touchon
et al., 2014; Karah et al., 2015).
In silico prediction and analysis showed that A144 and A155
genomes had the identical type I-Fb system found in strain
AYE, which consist of 6 cas genes (cas1-cas3-cas8f-cas5f-cas7f-
cas6f ). A144 and A155 systems contained each an identical
CRISPR array consisting of 53 spacers and repeat sequences
(Table 5). This finding supports the clonal relationship between
both strains. All 106 GC1 genomes from GC1 Group 1 and 2 had
the same cas operon (100% of query cover and 99.97%), and their
respective CRISPR arrays contained between 45 and 81 spacers
adjacent to the same repeat sequence (Table 5). We then analyzed
all the spacer sequences from A144 and AYE and we found that
most of them had a low degree of complementation to phage
related sequences from Staphylococcus aureus, S. epidermidis,
Klebsiella spp., Escherichia ssp., and other species usually found
in nosocomial niches (Supplementary Table 12).
TABLE 5 | Analysis of CRISPR-Cas system in GC1 genomes.



















The 6 cas1-cas3-cas8f-cas5f-cas7f-cas6f genes were identified in the eighteen
GC1 genomes of this study. All the repeats had the same sequence (5′-
GTTCATGGCGGCATACGCCATTTAGAAA-3′).
Frontiers in Microbiology | www.frontiersin.org 16 March 2020 | Volume 11 | Article 342213
fmicb-11-00342 March 16, 2020 Time: 15:28 # 17
Álvarez et al. Accessory Genome in IC1
Last, we investigated the dissemination of cas1-cas3-cas8f-
cas5f-cas7f-cas6f (8103 bp) in Outgroup Group 3, Outgroup
Group 4 and other genomes from GenBank. Blastn search
revealed that the locus was present in 121 out of 2956
A. baumannii non-GC1 genomes belonging to different sequence
types from Outgroup Group 4 with a nt identity that ranged from
97.42 to 99.89% as previously described (Supplementary Table 6;
Karah et al., 2015). Also, the locus was present in isolates from
other Acinetobacter species such as A. haemolyticus TG19602,
A. gyllenbergii NIPH 230 and in A. parvus as previously reported
(Touchon et al., 2014; Karah et al., 2015).
In vitro Competition of A144 and A155
To understand the success of GC1 in the nosocomial niche
with experimental data, we also investigated both the clonal
competition between A144 or A155 versus A118 (sporadic clone)
in the absence of antimicrobial pressure.
A144 and A118 showed slight differences in the growth rate.
The growth rate of A144 was r = 0.015 OD/min with a doubling
time Dt = 46.18 min. For A118, the growth rate was r = 0.015
OD/min with a doubling time Dt = 46.98 min. Conversely, A155
showed a faster growth in the conditions assayed, with values of
r = 0.017 OD/min, and a doubling time Dt = 40.98 min.
A144 showed a fitness advantage with an S-value
S = 0.333 ± 0.069 in the fitness assays for the clonal competition
between A144 and A118 carried out for 124 generations;
with a relative adaptive fitness F = 1.333 (133.318%) and a
fitness cost C = −33.318%. As expected, the clonal competition
between A155 and A118 carried out for 140 generations also
showed a fitness advantage (C < 15.574%) with an S-value
S = −0.156 ± 0.018, F = 1.156 (115.574%) and C = −15.574%.
The clonal competition assay showed a competitive advantage
of the GC1 strains over the sporadic clone in the two pairs
(A144/A118 and A155/A118) with the fitness cost C > 10%
and a statistically significant difference (P = 0.00001, P < 0.05).
Previous reports described that the greater the difference in
growth rate between two strains, the greater is the bacterial
burden difference over time (Guo et al., 2012); nevertheless,
differences i.e., in antimicrobial resistance and virulence factors
should be under consideration altogether. Here, the difference
between this two pairs of strains (A144/A118 and A155/A118)
showed the relevance of even small genomic modifications in the
fitness of a strain (A144 and A155) when competes with another.
Regarding virulence factors, A. baumannii usually encodes
a type VI secretion system (T6SS), which can be used to kill
competitors (Weber et al., 2013). It is likely that the presence of
this system may be associated to the survival in the nosocomial
niche (Fitzsimons et al., 2018). Here, we searched the genes
coding for the proteins critical for T6SS operation (Weber et al.,
2016; Repizo et al., 2019) in Groups 1, 2, 3 and 4, as well as
tetR1 and tetR2 repressors in Groups 1, 2 and 3 (Supplementary
Table 13). The genes coding for the core proteins of this
system were present in A144 and A155 and in all genomes
from GC1 Group 1 and 2 but NIPH290, GCF_000369185.1,
GCF_000369325.1, GCF_004347305.1_ASM434730v1 and
GCF_006494215.1_ASM649421v1 where the T6SS was
partially lost (101/106) (Supplementary Table 13). The
tetR1 and tetR2 repressor genes were not detected in
GC1 Group 1 and 2 but GCF_001512215.1_9179_4_6 and
GCF_006492525.1_ASM649252v1 genomes that harbored
tetR2 (tetR2 = 2/106). When we searched in the Outgroup
Group 3, we identified the complete T6SS in epidemic clones
and partially deleted in A118 which belongs to a sporadic
clone (Supplementary Table 13). Interestingly, both repressor
genes tetR1 and tetR2 were only present in Naval-13. In
Outgroup Group 4, which includes A. baumannii non-GC1
strains, we found that the 17.46% of draft genomes had
partially or complete lost components of the T6SS (2440/2956)
(Supplementary Table 13).
Taken together, the fitness of A144 and A155 over sporadic
clones, and the finding of complete T6SS in almost all GC1 strains
compared to non-GC1 genomes, suggests that these features can
be related to the epidemic behavior of the so-called clones that
can rapidly displaced sporadic clones or strains lacking the T6SS.
DISCUSSION
Genomic studies in combination with biological analysis led
us to identify maintenance along time of genes usually
subjected to LGT that may have a crucial role during the
evolutionary trajectory of the high-risk clone GC1. The genes
from the accessory genome acquired by GC1 strains were mostly
grouped in modules along the chromosome and preserved by
two adaptation pathways over time. On the one hand, the
paradigmatic AbaR GI, the CRISPR-Cas type I-Fb system, as well
as two novel regions of genome plasticity (RGP1 and 4), were
located within the same loci as “sedentary” modules (Figure 2).
In turn, the AbaR GI showed high plasticity evidenced by
several signs of microevolution including deletions, inversions
and duplications as previously described (Hamidian et al., 2016).
We found that even the AbaR0-type GI from our two strains
A144 and A155 isolated from the same hospital H1, presented
signs of microevolution since A144 isolated 3 years later than
A155 had acquired a duplicated mer operon and a Tn6018-R
(Figure 4). In concordance with these results, this region was
identified as a hotspot for recombination, corresponding to HS18
in our study (Figure 6). This is in agreement with the fact that,
to the best of our knowledge, there are no reports of AbaR GI
harboring identical genetic structure in A. baumannii strains
(Ramírez et al., 2013; Hamidian and Hall, 2018b). Otherwise, our
experimental studies revealed that AbaR GI is maintained over
time in A144 as well as in A155 without antimicrobial pressure
for at least one month. We can assume that there is a balance
between conservation and plasticity of particular regions of the
accessory genome, as previously described for the core genome
regions of A. baumannii (Touchon et al., 2014; Hamidian et al.,
2016). The other remaining “sedentary” modules, the cas genes
from the type IF-b CRISPR-Cas system, RGP1, and RGP4, did
not show signs of microevolution.
We confirmed the preliminary data reported by Karah
et al. (2015), since we found that the cas operon from AYE
was conserved in all the 106 GC1 genomes, supporting that
its acquisition occurred before GC1 clonal diversification
(Supplementary Tables 6, 12) but after speciation of
A. baumannii. It is particularly intriguing the complete identity
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found between the CRISPR-Cas systems, including the order
and identity of 53 spacers of both A144 and A155 strains from
the same hospital, considering that they were isolated at distant
time points (Table 5). It is highly probable that each strain was
exposed to different phages and plasmids; however, there is no
evidence of new invasions. Since the same cas genes from the type
IF-b CRISPR-Cas system were found in other GC1 chromosomes
and also in other species of the genus Acinetobacter carrying
different spacers (Karah et al., 2015; Supplementary Table 12),
it is likely that they are functional systems. Thus, it is possible
to assume that a tight regulation of these systems may have led
to a stable array for A144 and A155. In this regard, it has been
reported that phages can encode proteins with anti-CRISPR
activity that may inhibit their function (Pawluk et al., 2014;
Bondy-Denomy et al., 2015). Further studies are necessary to
confirm this hypothesis. This finding and the closeness observed
in the phylogenetic tree (Figure 1) suggest that A144 and A155
strains may share a common ancestor from which they adapted
and evolved within the H1 nosocomial niche.
Concerning the regions of genomic plasticity, we found
that RGP1 and RGP4 were highly conserved in the 106 GC1
genomes and absent in almost all other lineages of A. baumannii.
Ortholog genes of the RGP1 harboring 29 genes related to
LSU and SSU ribosome proteins were previously described
as an unusual multisequence alignment block structure with
important evolutionary implications (Vishwanath et al., 2004).
The implication of the RGP4 that includes a putative repressor
protein related to the TetR family which can act on various genes
with diverse functions such as biosynthesis, metabolism, bacterial
pathogenesis, and response to cell stress (Ramos et al., 2005;
Saranathan et al., 2017) remains unclear. The functional role of
both RGP1 and RGP4 in GC1 lineage would be an interesting
challenge to further investigate.
On the other hand, another module of the accessory genome
showed to be “mobile” though present in the 106 GC1 genomes
(Table 3). This is the case of the YMC/09/02/B1251_ABA_BP
putative prophage which showed to vary in length structure
across GC1 genomes (Table 3) and it was located in diverse
insertion sites as we identified in this study (Supplementary
Table 9). Ten additional prophages were detected in the
GC1 Group 1 genomes. The biodiversity of prophages as
well as the rearrangements they promote within each genome
reflects frequent events of successful phage invasion. Since
phages may acquire ORFs named morons (Hendrix et al.,
2000), the presence and the mobility of prophage Acinetobacter
YMC/09/02/B1251_ABA_BP in all 106 GC1 strains denotes it
may have an important role in acquisition of accessory genome
by LGT in this pandemic clone. In agreement with this, we
found also a process of deep microevolution for prophage 3
that is widespread in A. baumannii strains (Chan et al., 2015),
suggesting that prophages may play an important role for
genomic plasticity not only in GC1 but in all the species.
Interestingly, a particular genetic behavior was identified for
the IS. They showed a great variability in terms of IS families
and copy number, having each GC1 strain different amount of
IS in different chromosomal locations. There was no evidence
of a sequential acquisition of the IS in the distribution observed
among the 18 GC1 Group 1 genomes, indicating that the presence
of these genetic elements is likely to be related to the rapid
adaptation of the strains to the environment they are exposed
to. Hence, they may be involved in niche adaptation in GC1
strains. IS analysis also showed that A144 and A155 shared
some IS as a main difference with other GC1 Group 1 strains
(Figure 2), reinforcing our phylogeny data (Figure 1) that they
share a common ancestor. Other IS, such as IS26 and ISAba1were
frequent in GC1 Group 1 strains and they were identified in both
GC1 lineages. Remarkably, the GC1 Group 1 genomes did not
share a common IS (Supplementary Table 7). The fact that no
IS were detected in AB307-0294 genome supports the hypothesis
that IS may have been acquired after the diversification of
this clone and/or that IS are easily acquired and lost by GC1
strains. Besides, a great variety of IS were identified in plasmids
from GC1 Group 1 genomes suggesting that extrachromosomal
replicons, especially plasmids harboring Rep_3 replicases, may
contribute to the capture and flux of IS that later could invade
the chromosome. The relevance of Rep_3 replicases in the
acquisition of IS by the chromosome is reinforced by the fact that
this family of replicases were found in different species, families
and even phyla as well as in environmental or clinical strains
(Salto et al., 2018), which enhances the set of IS diversity that can
be captured by GC1 strains.
Concerning our genomic analysis related to antimicrobial
resistance, we found that the bioinformatic results matched
the multidrug resistant phenotype of A144 and A155 with
only slight differences in the ARG content (Tables 2, and
Supplementary Table 3). An interesting feature was found by
analyzing the naturally harbored β-lactamase genes ampC and
blaOXA−51−like in GC1. Both β-lactamase genes are ubiquitous
in A. baumannii strains (Merkier and Centrón, 2006; Karah
et al., 2017). Previously, several alleles of ampC were identified
(Karah et al., 2017). We found nine ampC alleles in the eighteen
genomes from our GC1 Group 1. Conversely, blaOXA−51−like
was identified as blaOXA−69 in 17/18 GC1 Group 1 genomes
except A388 which contained blaOXA−92 as previously described
(Pournaras et al., 2014). These results suggest different degrees
of genomic plasticity for each β-lactam resistance gene. This
feature is also supported by the identification of a hotspot of
recombination in the ampC flanking regions (Holt et al., 2016). It
is likely that different genetic behaviors of each β-lactamase gene
within the same cell may be a powerful tool to a more successful
response to antimicrobial selection in the nosocomial niche. The
sulbactam resistance in A144 and A155 may be explained by the
presence of the blaTEM−1 gene with the Pa/Pb promoters since
our results indicated that this gene/promoter combination could
be involved in the increase of the sulbactam MIC (Tables 2,
and Supplementary Table 3). Additional studies to effectively
quantify the level of increase in the MIC for sulbactam remain to
be done, but the evidence showed here correlates perfectly with
the results from other authors, which showed that that the Pa/Pb
promoters were stronger than the promoter P3 (Lartigue et al.,
2002; Krizova et al., 2013).
The fluoroquinolone resistance in A144 and A155 and of
the GC1 Group 1 (15/18 GC1 Group 1) correlated with the
results of Ostrer et al., which stated that it could be predicted
based solely on target gene quinolone-resistance mutations
for A. baumannii and that the primary mutation is followed
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by either of two mutations in the alternate target in this
species ParC88 ← GyrA81 → ParC84 (Ostrer et al., 2019).
Even when most of the GC1 Group 1 genomes showed
a predicted fluoroquinolone resistance due to mutation in
QRDR, it is remarkable the absence of PMQR genes in the
isolates analyzed here.
By focusing in the antimicrobial resistance adaptation of GC1
to XDR phenotypes, our data evidenced that class 1 integrons
were identified in 13 out of 18 GC1 genomes suggesting they
may play an essential role for acquisition of mobile antimicrobial
resistance. We identified one additional deleted attI1 site, which
may have arisen from deletions and rearrangements of previous
complete class 1 integrons within the AbaR GI of AYE. It is
likely that this fourth deleted attI1 was recognized as a secondary
site and at the same time it was related to the acquisition of
the novel allele aac(6′)-Ian which has not been found in other
isolates. It is likely that ARG cassettes could be captured by a
type 1 integron integrase from a complete class 1 integron and
inserted in the respective attI1 site or in secondary sites, which
may act as hotspots for active acquisition of mobile antimicrobial
resistance in nosocomial niches. In agreement with previous
results from our laboratory (Ramírez et al., 2015), only seven
class 2 integrons were identified in GC1 Group 1 and 2 strains
(n = 106), confirming that the prevalence of intI2 in A. baumannii
strains from Argentina is related to the emergence of novel
singletons and to the abundance of CC113/CC79, which has
been the local dominant lineage for several decades (Stietz et al.,
2013). On the other hand, the fact that 56 out of 106 GC1
strains harbored an intI1 gene, suggests a wide dissemination of
class 1 integrons in this pandemic clone. Taking together, these
results evidence a different epidemiology of multidrug resistant
integrons among A. baumannii lineages.
Regarding the investigation about the variability of three
resistance-nodulation-cell division-type efflux pumps in GC1,
we found that the 106 GC1 genomes contained all the genes
encoding the AdeABC, AdeFGH and the AdeIJK efflux pumps
altogether with their regulators with different levels of identity
for each gene, except for the partial deletion of AdeABC in
strain 9102 (Supplementary Tables 3, 6). Meanwhile, our study
showed that the three efflux pumps are subjected of processes of
genomic loss in non-GC1 strains, particularly those related to
adeABC genes (Supplementary Table 6). In this regard, it has
been previously suggested that adeABC was subjected to loss and
acquisition along time, while the adeFGH system is intrinsic to
the A. baumannii species (Coyne et al., 2010, 2011). Concerning
the molecular epidemiology of the adeABC genes, it has been
shown that this operon is present in ca. 80% (from 53% to 97%)
of A. baumannii strains and it is associated mainly with clinical
isolates since it has not been found in 32 environmental strains
(Huys et al., 2005; Chu et al., 2006; Hujer et al., 2006; Nemec
et al., 2007; Bratu et al., 2008; Chen et al., 2009; Lin et al., 2009;
Srinivasan et al., 2009). Moreover, Ab421 HEIGH-2010 strain
as well as other 10 clinical strains of A. baumannii belonging
to clone ST79/ST924 lacked these genes and were found to
display increased invasiveness (Rumbo et al., 2013; López et al.,
2017). Taking together the evidence, the adeABC genes from
A. baumannii may be suffering genomic losses resulting in its
presence in less than the 90% of the total genomes of the species
as also seen in our study (Supplementary Tables 3, 6), suggesting
that the adeABC efflux pump as part of the core genome could
be under consideration. We also have detected a deep process
of genomic loss of the T6SS in non-GC1 strains. It is likely
that the maintenance along time and continents of complete
AdeABC, AdeFGH and the AdeIJK efflux pumps related to
antimicrobial resistance as well as the T6SS which is associated
to kill competitors (Weber et al., 2013) may contribute to the
survival of GC1 in the nosocomial niche. Although the huge
pangenome of A. baumannii (Touchon et al., 2014; Chan et al.,
2015) evidences dynamic processes of loss and gain of genes, the
maintenance of some blocks of accessory genome within a lineage
suggests that the general idea that all genes acquired by LGT are
easily lost, should be analyzed more deeply in biological models.
We identified an essential role of still unknown properties
of “mobile” and “sedentary” accessory genome that is preserved
over time under different antibiotic conditions and nosocomial
habitats having a decisive role in the adaptive success of
the pandemic GC1. In fact, it may be associated with the
survival under stress conditions of GC1, which is reflected
in its perpetuation along time in strains from different
continents. At the same time, our data suggests that GC1 is
constantly evolving and adapting to novel niches by exposure
to a continuous acquisition of IS which may contribute to
the instantly adaptation to the changing stresses suffered by
the trajectory of GC1 strains. In these processes, plasmids
harboring rep_3 replicases might have an important role
for the flux of IS and antimicrobial resistance determinants.
Not only genomic plasticity in A. baumannii is evidenced
by hotspots for recombination, gene duplications, deletions
and/or insertions (Touchon et al., 2014; Holt et al., 2016),
but also for the maintenance of several modules of accessory
genome, such as RGP1 and RGP4, CRISPR-Cas system, AbaR
GI as previously found (Holt et al., 2016), mobile prophage
YMC/09/02/B1251_ABA_BP as well as the preservation of
synteny of genomes belonging to GC1, being these traits pivotal
for the success of this high-risk clone. Competition assay of
A144 as well as A155 versus A118 without antimicrobial pressure
suggested a greater ability of GC1 to thrive over the clones with
sporadic behavior, which in conjunction with the presence of
a complete T6SS and efflux pumps in almost all GC1 genomes
can explain from an ecological perspective the success of this
pandemic clone to spread and survive in hospital environments.
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